Jim Joseph, Ph.D.


Dr. Jim Joseph is the Executive Director of Biology at Apeiron Therapeutics. He has over 15 years of small molecule oncology drug discovery experience leading research teams supporting preclinical activities ranging from new target identification and validation to translational biology supporting ongoing clinical trials. Most recently Jim was an Associate Director at Ideaya Biosciences where he led the new target identification and validation activities. Prior to Ideaya, Jim directed the in vitro biology activities for the androgen receptor (Erleda®) and estrogen receptor antagonist programs at Aragon and Seragon Pharmaceuticals, respectively. Jim completed his Ph.D. in Pharmacology at Duke University and is an author on over 25 publications and patents.